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ABSTRACT
Regulation of mRNA translation is an important
mechanism determining the level of expression of
proteins in eukaryotic cells. Translation is most
commonly initiated by cap-dependent scanning,
but many eukaryotic mRNAs contain internal
ribosome entry segments (IRESs), providing an
alternative means of initiation capable of indepen-
dent regulation. Here, we show by using dicistronic
luciferase reporter vectors that the 5’-UTR of the
mRNA encoding human insulin receptor (hIR) con-
tains a functional IRES. RNAi-mediated knockdown
showed that the protein PTB was required for max-
imum IRES activity. Electrophoretic mobility shift
assays confirmed that PTB1, PTB2 and nPTB, but
not unr or PTB4, bound to hIR mRNA, and deletion
mapping implicated a CCU motif 448nt upstream of
the initiator AUG in PTB binding. The IR-IRES was
functional in a number of cell lines, and most active
in cells of neuronal origin, as assessed by luciferase
reporter assays. The IRES was more active in con-
fluent than sub-confluent cells, but activity did not
change during differentiation of 3T3-L1 fibroblasts
to adipocytes. IRES activity was stimulated by
insulin in sub-confluent cells. The IRES may function
to maintain expression of IR protein in tissues
such as the brain where mRNA translation by cap-
dependent scanning is less effective.
INTRODUCTION
Regulation of mRNA translation is an important mecha-
nism determining the level of expression of many proteins
in eukaryotic cells. At least two distinct mechanisms are
used to bring ribosomes to the mRNA. In the most
commonly used process, termed cap-dependent scanning,
a protein complex eIF4F (comprised of eIF4E, the cap-
binding protein eIF4G, a large scaffold protein and
eIF4A, a dead box helicase) interacts initially with the
50-end of the mRNA and, via the interaction of eIF3
with eIF4G, recruits the 40S ribosomal subunit (1). In
the alternative process (internal ribosome entry), the 50-
untranslated region (50-UTR) of the mRNA is capable, in
the presence of trans-acting factors, of adopting a highly
complex structure (internal ribosome entry segment,
IRES) that allows the ribosome to be acquired to a site
that can be a considerable distance from the 50-end of the
mRNA (2,3). The proteins required for this process have
yet to be fully identified although it has been found that
many cellular and viral IRESs require polypryimidine
tract binding protein (PTB) for activity (4,5). Cellular
IRESs are generally used under patho-physiological con-
ditions when cap-dependent scanning is compromised, for
example during polio virus infection (6), apoptosis (7),
mitosis (8), genotoxic stress (9) and heat shock (10).
Overall, around 10% of mRNAs have potential for their
translation to be initiated by internal ribosome entry (11).
However, the subsets of mRNAs that are still translated
under different conditions are distinct, suggesting that in
each condition there is co-ordinated translational regula-
tion dependent on specific elements. Certain families of
highly related mRNAs have also been shown to be trans-
lated by internal ribosome entry, for example the Myc
family of genes (12–15). The IRESs found in the c-,
L- and N-myc 50-UTRs require a common set of trans-
acting factors (ITAFs) for their activity suggesting that
they may be regulated in a similar manner (16). IRES-
mediated translational regulation is also prevalent
amongst growth factors and growth factor receptors.
Translation initiation on a number of growth factor
mRNAs (IGFII, PDGF2, TGF-b, FGF-2 and VEGF) is
specifically regulated during differentiation, growth and
stress (17). The mRNAs encoding mammalian insulin
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like growth factor-1 receptor (IGF-1R) (18), angiotensin
type I receptor (19), vasopressin v1b receptor (20) and
TrkB neurotrophin receptor (21) all contain functional
IRESs. The Drosophila insulin-like receptor mRNA con-
tains an IRES that coordinates physiological signals
responsible for monitoring nutrient and cell growth con-
ditions (22).
The level of insulin receptor (IR) expression is an
important determinant of cellular insulin sensitivity, but
mechanisms regulating IR expression are poorly under-
stood. The IR is widely distributed in almost all mamma-
lian tissues but levels of expression vary widely in different
cell types, being highest in classical insulin target tissues
such as liver and adipose tissue (23). The IR gene pro-
moter was characterized almost 20 years ago and shown
to contain elements typical of housekeeping genes as well
as elements responsive to glucocorticoids and insulin
(24,25). More recently, up-regulation of IR mRNA
induced by serum deprivation was shown to involve the
transcription factor FOXO1 (26). It has long been known
that prolonged exposure of cells to insulin induces IR
down-regulation via internalization and enhanced protein
degradation (27). However, the regulation of mammalian
IR expression at the level of mRNA translation has not
previously been reported. Here, we show that the mRNA
encoding human IR contains an IRES which is dependent
on PTB and nPTB for activity in vitro and in vivo.
The activity of this IRES differs between cell types and
it is stimulated by insulin.
MATERIALS AND METHODS
Cloning and sequencing of HIR 5’-UTR
Primers were designed to amplify human insulin receptor
(HIR) 50-UTR based on previously identified transcription
start sites (28) and using RNA extracted from human
epithelial carcinoma (HeLa) cells. A single product of
the expected size (540 nt) was obtained and sequenced.
The sequence was identical to that in the human genome
database (Homo sapiens chromosome 19 genomic contig,
reference assembly; version NT_011255.14, GI:37552371),
which differs slightly from the published sequence (28).
Following digestion with EcoR1 and Nco1 the fragment
was inserted into the dicistronic reporter vector pRF (10)
and into the vector pRBRF, a dicistronic promoterless
construct described previously (29).
Cell culture and transient transfections
3T3-L1 cells were cultured and differentiated as described
previously (30). Other cell lines N1E-115 (mouse neuro-
blastoma), HeLa, N2A (mouse neuroblastoma), NB2a
(neuroblastoma originating from mouse cortex), MCF7
(derived from human breast adenocarcinoma) and B50
(neuroblastoma derived from rat hippocampal neurons)
were cultured using conditions described on the ATCC
web page (see www.atcc.org). Cells were transfected
using FuGene 6 (Roche) following the supplier’s instruc-
tions, or with calcium phosphate (31).
The activities of firefly and Renilla luciferases in in vitro
translation reactions or lysates prepared from transfected
cells were measured using a Dual-Luciferase reporter
assay system (Promega) and light emission was measured
over 10 s using an OPTOCOMP I luminometer. The
activity of b-galactosidase in lysates prepared from
cells transfected with pb-Gal was measured using a
Galactolight plus assay system (Tropix). IRES activity
was calculated as the average of (IRES-driven firefly
luciferase expression/b-Gal expression). Errors were calcu-
lated as the standard deviation of the three calculated
IRES activities, and expressed as a percentage of the
average activity.
Quantitative RT–PCR
Total cellular RNA was isolated from parallel transfec-
tions using the RNAqueous kit (Ambion) according to
the manufacturer’s protocol and treated with Turbo
DNase (Ambion) to ensure that any contaminating geno-
mic or plasmid DNA was removed. Total cDNA for
quantiative PCR assay was prepared from total RNA
with the Improm II Reverse Transcription System
(Promega) using random primers. The Power SYBR
Green PCR Kit (Applied Biosystems) was used to detect
Renilla and firefly luciferase mRNA, using the primer
pairs Ren1 (forward primer, TTTACATGGTAACGCG
GCCT; reverse primer, GGTCTGGTATAATACACC
GCGC; amplifying bases 146–210 of the Renilla ORF),
Ren2 (forward primer, GTTTATTGAATCGGACCC
AGGA; reverse primer, CCCATTTCATCAGGTGCA
TCTT; amplifying bases 758–865 of the Renilla ORF)
and Fire1 (forward primer, GAAGAGATACGCCCTG
GTTCCT; reverse primer, TGTCCACCTCGATATGT
GCATC; amplifying bases 90–130 of the firefly ORF)
which were designed using the Primer Express Program
v2.0 (Applied Biosystems). Amplification reactions were
carried out and analysed using a Stratagene Mx3000P
Real-Time PCR System, with a standard curve of pRF
plasmid DNA diluted over five orders of magnitude
used to quantify the amount of starting template in each
sample. All assays were carried out in triplicate on three
independent occasions.
Reduction of PTB expression by RNAi
On day one, HeLa cells were seeded at a density of 105
cells per well of a 24-well plate and grown overnight in
DMEM 10% FCS. On day two, 6 ml of a 20 mM stock of
siRNAs PTB P1 (AAC UUC CAU CAU UCC AGA
GAA) and C2 (AAG GUC CGG CUC CCC CAA
AUG) (32) were mixed with 44 ml Optimem-1 medium
(Invitrogen), and then combined with a mixture of 3 ml
Lipofectamine 2000 (Invitrogen) and 12 ml Optimem-1
and incubated at room temperature for 25min. A further
38 ml of Optimem-1 was added, and 100 ml of the mixture
transferred to the cells. On day three, the cells were
washed with PBS, detached from the plate by addition
of 120 ml of trypsin/EDTA and incubation at 378C for
2–3min. DMEM (380ml) was added and the cells then
split equally between three wells of a 24-well plate, each
containing 0.5ml of DMEM/FCS. On day four, the cells
were transfected with siRNA as on day two, except that
one-third of the quantities were used per well. On day four
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0.3 mg of dicistronic reporter per well was transfected using
FuGene6 (Roche) according to the manufacturer’s
instructions. The cells were harvested on day seven and
luciferase activity was determined.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSAs) were pre-
formed as described previously (33) using 23 000 c.p.m.
of labelled transcript which was incubated with unr
(0.2 mg) and/or PTB isoforms (0.1 mg) at room temperature
for 10min. Loading buffer was added and samples loaded
directly onto 5% or 10% acrylamide TBE gels that were
then electrophoresed at 150V for 1 h. Gels were dried and
exposed on a PhosphorImager.
In vitro transcription reactions
Vector DNA was linearized by restriction digestion using
a site downstream of the region of interest (HpaI for dicis-
tronic, NcoI for monocistronic); transcripts were synthe-
sized in a reaction mixture containing 1 transcription
buffer [40mM HEPES–KOH (pH 7.9), 6mM MgCl2,
2mM spermidine, 10mM dithiothreitol (DTT),
10mM NaCl], 40U RNAguard or RNasin, 1mM ATP,
1mM UTP, 1mM CTP, 0.5mM GTP, 1mM
m7G(50)ppp(50)G, 1 mg DNA template and 20U T7 or
T3 RNA polymerase to a final volume of 50 ml. For
radiolabelled RNAs, CTP was replaced with 50 mCi
[a-32P]CTP. For biotinylated RNA, the transcription reac-
tions were supplemented with 0.1mM biotin UTP. The
reaction mixture was incubated at 378C for 1.5 h and the
RNA purified.
Protein expression
Unr with a C-terminal His-tag was purified from cultures
of Sf9 cells that had been infected with a recombinant
baculovirus expressing unr-His, according to the supplier’s
instructions (Qiagen). Cells were harvested, lysed in
phosphate-buffered saline containing 0.1% Triton, and
the tagged protein purified on a Nickel affinity column.
His-tagged PTB1, PTB2, nPTB and hnRNPK were over-
expressed in Escherichia coli from PET28a vector by addi-
tion of IPTG to the growth medium and proteins were
again purified using a Nickel affinity column (29).
In vitro translation reactions
The rabbit reticulocyte flexi-lysate in vitro translation
system (Promega) was primed with 5 ng/ml RNA and
used according to the manufacturer’s instructions. The
reaction was performed in a final volume of 12.5 ml and
0.5–2mg of each protein was added where appropriate.
Luciferase activities were assayed as described above,
and the firefly and Renilla values expressed relative to
the control plasmid pRF, which was assigned a value
of 1. All experiments were performed in triplicate on at
least three independent occasions.
SDS–PAGE and western blotting
Cell extracts were prepared as described previously (34),
subjected to electrophoresis on SDS–polyacrylamide
gels and the proteins transferred to polyvinylidene difluor-
ide (PVDF) membrane (Millipore). Blots were probed
with anti-PTB monoclonal antibody (derived from the
BB7 hybridoma), or with anti-actin antibody (Sigma) as
loading control, and reactions visualized using chemilumi-
nescent reagents.
Secondary structure prediction
Chemical structure probing was performed exactly as
described previously (29). Secondary structure predictions
were generated using the web implementation of theMfold
algorithm incorporating version 3.0 of the Turner rules.
RESULTS
The IR 5’-UTR contains an IRES
Transcription of the human IR gene is initiated at several
sites around 540 nt upstream of the translation start site
(28). The 50-UTR of the human IR mRNA is long and
GC-rich and is highly conserved between species, the
mouse and rat mRNAs showing 70% identity to the
human sequence consistent with functional significance
of this region (Figure 1). The IR 50-UTR is similar in
this regard to that of the highly related type I IGF-1R
which has been shown to contain an IRES (18). To test
Figure 1. 50-UTRs of human and rat IR mRNA. The 50-UTR of hIR
mRNA, as previously defined (28) was amplified from HeLa cells. The
sequence determined was identical to that in the human genome database
(Homo sapiens chromosome 19 genomic contig, reference assembly;
version NT_011255.14, GI:37552371). This sequence differs slightly
from that published when the transcription start sites were determined
(28). The 50-UTR of rat IR mRNA has not been formally defined, and
the rat sequence shown is from rat genome database (Rattus norvegicus
chromosome 12 genomic contig, reference assembly, Version
NW_047365.1, GI:34870143). Polypyrimidine tracts in the human
sequence are underlined, and CCU motifs indicated in bold. The trans-
lation start codon is indicated in italics.
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whether the IR 50-UTR also contains an IRES the corre-
sponding DNA was obtained by RT–PCR and inserted
into the dicistronic reporter vector pRF (Figure 2A).
This vector contains the Renilla and firefly luciferases as
the upstream and downstream cistrons respectively and an
increase in firefly luciferase activity is indicative of an
IRES in the preceding sequence (10). The resulting plas-
mid (pRIRF) was transfected into HeLa cells and luci-
ferase activity was determined. The presence of the IR
50-UTR stimulated the translation of the firefly luciferase
approximately nine times over that attributable to read-
through (Figure 2Bi). To rule out apparent IRES activity
resulting from enhanced read-through the IR 50-UTR was
inserted into the vector phpRF that contains a stable hair-
pin upstream of the Renilla cistron. The presence of the
hairpin reduced the activity from the Renilla cistron by
70% but had no effect on the amount of firefly luciferase
produced (Figure 2Bii). To ensure that the IRES activity
was not due to the presence of cryptic promoters in the
50-UTR of IR the DNA corresponding to this region was
inserted into the vector pBRRF which does not contain a
promoter. This vector was again transfected into HeLa
cells and luciferase activity was determined. No luciferase
activity was detected showing that there was no promoter
present in this region (Figure 2Biii). To determine whether
increases in firefly luciferase expression were due to an
increase in monocistronic mRNAs being produced by
alternative splicing events that removed the Renilla ORF
or by cryptic promoter activity, a quantitative real-time
PCR assay was carried out to determine the amount of
reporter mRNA (Figure 2Biv). Two amplicons were
chosen within the Renilla ORF (Ren1 and Ren2) with
the firefly amplicon (Fire1) selected close to the AUG ini-
tiation codon. A ratio of 1 : 1 of firefly :Renilla mRNA
would be expected in an intact dicistronic message and
is indeed observed in mRNA from the control vector
pRF, and also in a vector containing the IRES from
EMCV. Insertion of the insulin receptor 50-UTR between
the cistrons of the pRF vector results in a change in the
ratio between the cistrons. However, as the resulting ratios
are less than 1, this suggests that there is no cryptic pro-
moter activity in the IR 50-UTR, and there is no evidence
for a cryptic splicing event that results in loss of the
Renilla cistron (both events which would lead to the
production of functional, capped, monocistronic firefly
luciferase mRNAs that would be translated by the cap-
dependent scanning mechanism). Taken together these
data strongly suggest that IR 50-UTR contains a func-
tional IRES.
The IR-IRES requires PTB for activity in vitro and
in cultured cells
We have shown previously that PTB is a general IRES-
trans-acting factor binding to CCUn in polypyrimidine
rich stretches of RNA (4). To determine whether IR-
IRES activity was sensitive to a reduction in the levels
of PTB in cultured cells RNAi was used to reduce expres-
sion of this protein (Figure 3Ai). The dicistronic vector
that contains the IR-IRES was transfected into these
cells and luciferase activity was determined (Figure 3Aii).
IR-IRES activity was reduced to 50% of the untreated
values by RNAi suggesting strongly that PTB is an ITAF
for IR-IRES cells grown in culture (Figure 3Aii).
To determine whether the IR-IRES was able to interact
with PTB from cultured cells, biotinylated RNA was tran-
scribed in vitro from cut plasmid DNA which contained
the IR-IRES element (pSKIRL) or from a control
GAPDH plasmid (pSKGAP) and incubated with HeLa
cell cytoplasmic extracts. RNA/protein complexes were
purified using magnetic beads which contained strepavidin
as described previously (16). After extensive washing, pro-
teins were eluted with buffer containing 300mM NaCl
and the products were separated by SDS–PAGE and
immunoblotted for PTB. The data show that PTB inter-
acts preferentially with IR-IRES RNA, relative to the
GAPDH control sequence (Figure 3Bi).
In mammalian cells there are three widely distributed
isoforms of PTB, namely PTB1, PTB2 and PTB4, and a
paralog nPTB that has enhanced expression in neuronal
tissue (5). The RNAi used would decrease the levels of
PTBs -1, -2 and -4 therefore assays were performed
in vitro to identify whether any one of these proteins pre-
ferentially interacted with the IR-IRES. EMSAs were
carried out using purified PTB isoforms and additional
proteins that have been shown to bind other cellular and
viral IRESs. Radiolabelled IR-IRES RNA generated by
in vitro transcription reactions was incubated with the
purified proteins. A complex that migrated more slowly
was observed when IR-RNA was incubated with
hnRNPK, PTB1, PTB2 and nPTB but not unr or PTB4
(Figure 3Bii) or a number of additional potential ITAFs
including PCBP1, PCBP2 or La (data not shown). It has
been shown for the Apaf-1 IRES that unr only binds in
the presence of PTB1, however no binding of unr to the
IR-IRES was observed in the presence of PTB1 (data not
shown). To confirm that the interaction with these pro-
teins and the IR-IRES-RNA was specific, EMSAs were
performed using GAPDH RNA. In this case, there was
no shift in the presence of these proteins (Figure 3Bii).
Interestingly, although the molecular weights of PTB1,
PTB2 and nPTB are almost identical the IR-IRES RNA
migration was delayed to very different extents by these
three proteins (Figure 3Bii). This could suggest that the
number of PTB molecules interacting with the RNA dif-
fers for different isoforms, or that the IR-IRES RNA
adopts alternative structures upon binding to these three
different yet highly related proteins.
Most cellular IRESs are inactive in vitro suggesting an
absolute requirement for ITAFs that are not present in
these systems (35). To test whether these proteins were
also able to stimulate IRES activity in vitro dicistronic
RNA was derived from pRIRF and pRF and was used
to prime reticulocyte lysates which were supplemented
with the proteins indicated (Figure 3C). There was stimu-
lation of IR-IRES activity in the presence of PTB1 and
nPTB by 2- and 3.5-fold, respectively and a smaller but
significant stimulation was observed with hnRNPK and
PTB2. There was no additive effect on IRES activity by
combinations of PTB and unr (Figure 3C) or hnRNPK
with PTB isoforms (data not shown). To confirm that the
stimulation of protein synthesis from the firefly cistron
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Figure 2. The 50-UTR of hIR mRNA contains an IRES. (A) Schematic representation of the constructs pRF, pRIRF, pHPRIRF and pBRRIRF.
(B) IRES activity was demonstrated using bicistronic vectors and controls. Data shown are mean  SD of three independent experiments
(each involving triplicate assays). (i) The plasmids pRF and pRIRF were transfected into HeLa cells and luciferase activity was determined.
The value shown is the ratio firefly activity/Renilla activity relative to the transfection control b-galactosidase. (ii) The IR 50-UTR was subcloned
into the vector phpRF (10) which contains a stable hairpin upstream of the Renilla luciferase cistron to inhibit ribosome scanning. This vector was
transfected into HeLa cells and luciferase activities determined and the values expressed relative to those of the transfection control b-galactosidase
and relative to pRIRF which was set at 100%. (iii) IR 50-UTR was subcloned into the dicistronic promoterless vector pBRRF, creating pBRRIRF,
to test whether apparent IRES activity might instead reflect a cryptic promoter. Lucifersae activities were determined as in (ii). (iv) Quantitative
real-time PCR assays were carried out to determine the amount of reporter mRNA and to measure whether increases in firefly luciferase expression
were due to an increase in monocistronic mRNAs being produced by alternative splicing events that removed the Renilla ORF or by cryptic
promoter activity. Two amplicons were chosen within the Renilla ORF (Ren1 and Ren2 (shown in A) with the firefly amplicon (Fire1) selected
close to the AUG initiation codon. Amounts of mRNA from each amplicon were assayed and compared to a standard curve generated from pRF
plasmid DNA, from which equal amounts of firefly and Renilla cDNA are amplified. In the transfected samples, a similar ratio of firefly :Renilla
mRNA would be expected in an intact dicistronic message. Results from a dicistronic vector containing the viral IRES from EMCV are shown
for comparison.
Nucleic Acids Research, 2009, Vol. 37, No. 17 5885
Figure 3. The IR-IRES requires PTB for activity in vivo and in vitro. (A) Cells were transfected with siRNA to reduce the expression of PTB (P1) or
scrambled control siRNA (C2) and then transfected with the plasmid harbouring the IR-IRESs (pRIRF) or the vector control (pRF). (i) Cells were
harvested and lysed and a proportion of the resulting material was immunoblotted using antibodies against PTB, or against actin as a loading
control. (ii) Samples were assayed for firefly and Renilla luciferase activity and the IRES activity was calculated as firefly activity relative to
the transfection control b-galactosidase (ii). Data shown are meanSD of three independent experiments (each involving triplicate assays).
(Bi) Biotinylated IR-IRES or GAPDH (control) RNA was incubated with HeLa cell lysates. Protein/RNA complexes were isolated on
strepavadin-agarose beads, eluted and subjected to SDS–PAGE. The gels were transferred to nitrocellulose and probed with anti-PTB antibodies.
(Bii) EMSAs were performed using radiolabelled IR-IRES or GAPDH RNA which was incubated with 0.2 mg of unr, hnRNPK, or PTB1-4.
Products were separated on a 5% TBE polyacrylamide gel. The thick arrow indicates the position of the unshifted band, thinner arrows indicate
the positions of shifted bands. (Ci) In vitro translation reactions were performed in reticulocyte lysates primed with 100 ng of capped pRIRF RNA
and 50–200 ng of PTB1-4, hnRNPK and unr, either alone or in combination. IRES activity is expressed relative to the reactions that were carried out
in the absence of trans-acting factors and this value was set to 1. All experiments were performed in triplicate on three independent occasions. (Cii)
In vitro translation reactions were performed in reticulocyte lysates primed with 100 ng of ‘A’ capped pRIRF RNA and 100 ng of either PTB or
nPTB-1. IRES activity is expressed relative to the reactions that were carried out using RNA that contained a ‘G’ cap in the absence of trans-acting
factors and this value was set to 1. All experiments were performed in triplicate on three independent occasions.
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was due to enhanced IRES activity, RNA transcripts were
derived which contain an ‘A’ cap rather than a ‘G’ cap and
these were used to prime rabbit reticulocyte lysates. The
data show that, as expected, there is a reduction in the
synthesis of Renilla luciferase from these transcripts but
no effect on IRES-mediated firefly luciferase expression
(Figure 3Cii). Moreover, addition of PTB or nPTB to
the in vitro translation reaction that contained the ‘A’
cap mRNAs caused the same degree of stimulation of
IRES-activity as before (Figure 3Cii).
Identification of the minimal active element
It has been shown previously that PTB interacts with cel-
lular IRES RNA in polypyrimidine rich regions of RNA
that contain one or more repeats of (CCU)n (4). Deletion
mapping was performed to identify the minimal active
element of the IR-IRES to locate any such motifs.
Primers were designed to various regions of the IR
50-UTR and a series of fragments was generated. For
example, using primer 1 as the forward primer and
primer a, as the reverse primer, the fragment 1a was gen-
erated (Figure 4). These fragments were then sub-cloned
into the dicistronic vector pRF, and the corresponding
set of constructs were transfected into HeLa cells and
luciferase activity was determined (Figure 4A). Using
this approach the minimal active element was found to
reside in fragment 2a which spans a 180-nt region from
90 to 270 in the IR 50-UTR (451–271 nt upstream of the
Figure 4. The minimal active IR-IRES element contains two CCU motifs. (Ai) DNA fragments from insulin receptor were amplified by PCR using
oligonucleotides at the position shown and inserted into the dicistronic construct pRF at the EcoRI and NcoI sites. (Aii) Dicistronic constructs
containing the full-length 50-UTR sequence or fragments were transfected into HeLa cells. All constructs were co-transfected with pcDNA3.1/
HisB/lacZ. The ratio of Renilla luciferase and firefly luciferase activities were determined and normalized to b-galactosidase activities.
(Bi) Potential PTB binding regions within the minimal active element (91–270) are indicated by underlining. (ii) EMSAs were performed using
radiolabelled fragments of IR-IRES RNA incubated with 0.2 mg of PTB1 or nPTB. Products were separated on a 5% TBE polyacrylamide gel.
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translation start site) (Figure 4A). It is likely therefore that
elements that are required for IRES function are present
in this region of RNA and indeed there are two CCU
motifs within polypyrimdine rich stretches of RNA are
located at 93–95 and 172–174 (Figures 1 and 4Bi).
To characterize further the elements that bind PTB,
EMSAs were performed using radiolabelled RNAs that
spanned the 50-UTR. Fragments 1c, 2a and 2d, containing
both the 93–95 and 172–174 CCU motifs, interacted with
PTB1 and nPTB as indicated by the retarded RNA species
observed in each case, whilst fragments 3a, 4b and 5c did
not interact with PTB or nPTB (Figure 4Bii). Fragments
4b and 5c lack both the 93–95 and 172–174 CCU motifs
while fragment 3a, comprised of a 100-nt region from
170–270, does contain the second CCU motif (172–174),
albeit at its extreme 50-end.
To obtain further insight into the IR-IRES a structural
model of the 50-UTR was generated. RNAse V1 (which
cleaves double-stranded RNA) and chemical modifying
agents (DMS, kethoxal) were used to probe the RNA
as described previously (29), and the data obtained
(Supplementary Data 1) were used to constrain the
Mfold algorithm. The resulting model (Figure 5) has
extensive secondary structure, within which the proposed
PTB binding sites at 93–95 and 172–174 are both present
in stems that contain bulges. The model predicts that the
structural context of the PTB binding site at 172–174
would likely be preserved in the minimal active fragment
2a, although the context of the site at 93–95 would be
severely compromised.
The IR-IRES activity is increased by cell density
Activity of cellular IRESs varies between cell lines pre-
sumably reflecting differences in the expression of IRES-
trans-acting factors (3,29). Since the IR-IRES was shown
to be activated in vitro by PTB isoforms and particularly
by nPTB the IR-IRES function in a number of cell lines
was determined particularly those of neuronal origin,
which have been shown previously to express high levels
of nPTB including SY5Y, N2a, NIE115, NB2a (29). These
cell lines were transfected with pRIRF and luciferase
activity determined (Figure 6A). The IR-IRES was
found to be active in a range of cell lines but especially
so in certain neuronal cell lines, e.g. in SY5Y cells the IR-
IRES is twice as active as in HeLa cells (Figure 6A) and is
similar in this regard to both the N-myc and Apaf-1 IRESs
that also require nPTB for function (13,33). The exception
to this was the cell line B50, originally derived from rat
hippocampal neurons, in which IR-IRES activity was low.
The reason for low IR-IRES function in these cells is not
clear but could be due to species differences or differential
expression of additional ITAFs that are required for
IR-IRES activity.
There was a considerable variation in IR-IRES
mediated translation between experiments and the IRES
appeared to be more active in confluent cultures. To inves-
tigate this phenomenon further HeLa, B50, SY5Y and
NIE115 cells were plated at a range of densities and
were transfected with the IR-IRES (Figure 6B). Activity
of the IR-IRES increased with cell density in all cases, the
greatest effect being observed in SY5Y cells with an eight
fold difference in the amount of firefly luciferase produced
in confluent cells when compared to sub-confluent cells
(Figure 6Biii). There was no change in Renilla luciferase
activity in sub-confluent cells.
We also investigated whether IRES activity was altered
during differentiation of murine 3T3-L1 fibroblasts into
Figure 5. Predicted secondary structure of IR 50-UTR. The IR-IRES
RNA was probed with chemicals and enzymes (see Supplementary 1)
and the data were used to constrain secondary structure predictions
generated using the web implementation of the Mfold algorithm incor-
porating version 3.0 of the Turner rules. The positions of the two PTB
binding sites (CCU motifs) are marked.
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adipocytes, as it is known that IR expression increases
dramatically during differentiation (36). Confluent fibro-
blasts transfected with the dicistronic reporter were stimu-
lated to differentiate by adding a cocktail of insulin,
isobutylmethylxanthine and dexamethasone. Although
there were some changes in control (Renilla) luciferase
expression during the course of differentiation, IRES
activity as indicated by the ratio of firefly to Renilla activ-
ity did not change (data not shown).
The IR-IRES is stimulated by insulin
We have shown previously that increased cell contact of
B-cells stimulates signalling through the mTOR pathway
Figure 6. The activity of the IR-IRES is dependent upon cell type and cell density. (A) The cell lines shown were transfected with IR-IRES and
luciferase activity was determined. IRES activity is expressed using the ratio of the downstream cistron expression to upstream cistron with any
differences in transfection efficiencies corrected for using the b-galactosidase transfection control. All experiments were performed in triplicate on
three independent occasions. (B) To determine whether differences in cell density affect IR-IRES function HeLa (i), B50 (ii), SY5Y (iii) and NIE115
(iv) were transfected with the IR IRES at the cell densities shown. IRES activity is expressed using the ratio of the downstream cistron expression
to upstream cistron relative to the b-galactosidase transfection control. There was no change in Renilla luciferase activity in sub-confluent cells.
All experiments were performed in triplicate on three independent occasions.
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and the translational up-regulation of c-myc (37). The role
of insulin in signalling and cell proliferation is well estab-
lished and its effects on translation are mediated through
the mTOR pathway (38). Therefore experiments were
performed to determine whether it was possible to mimic
the cell density effect by the addition of insulin to cultured
cells (Figure 7). SY5Y and HeLa cells were seeded at
either low or high density, transfected with the IR-
IRES-containing construct and then treated with insulin
and luciferase activities determined at the times shown.
There was a rapid induction in the amount of luciferase
produced in all cases in the sub-confluent cells to a level
that was the equivalent that observed in confluent cells
(Figure 7Ai, Bi and Ci) yet there was no stimulation of
firefly luciferase production from IR-IRES in confluent
cultures (Figure 7Aii, Bii, Cii). This effect was specific to
the IR-IRES and no stimulation by insulin was observed
for the IRESs found in c-myc, Apaf-1 or BAG-1 (data not
shown). The relative firefly luciferase activity stimulated
by insulin did not reach the levels observed in the cells
grown at 120 000 per well suggesting that additional
pathways may be involved in this response.
In confluent, differentiated 3T3-L1 adipocytes, IRES
activity indicated by the ratio firefly/Renilla luciferase
was not significantly affected by incubation with insulin
(100 nM), phorbol myristoyl acetate (1 mM) or fetal bovine
serum (10%) for 1h or 4 h (data not shown).
DISCUSSION
We have shown that the 50-UTR of mRNA encoding
human IR contains an IRES, which allows protein syn-
thesis to be initiated by cap-independent mechanisms
(Figure 2). The 50-UTR of IGF-1R mRNA also contain
an IRES (18,39), as does the Drosophila insulin/IGF-like
receptor (dINR) mRNA (22). Despite a high degree of
sequence similarity between the IR and IGF-1R coding
regions, there is no discernable sequence similarity
between the respective 50-UTRs, although for both recep-
tors the 50-UTRs are well conserved between species
(70% identity, human vs rat/mouse). The human IR
50-UTR is 540 nt in length, and deletion analysis
indicated that a region 90–270 from the transcription
start site (or 451–271 nt upstream of the translation
Figure 7. The IR-IRES is stimulated by insulin in subconfluent cells. SY5Y (A) or HeLa (B) cells were seeded at a density of either 3250 cells per well
(Ai and Bi) or 6000 cells per well (Aii and Bii). Cells transfected with the IR-IRES-containing construct were treated with 100 nM insulin and
luciferase activities determined at the times shown. Luciferase activity is expressed as the ratio of Firefly/Renilla luciferase relative to the transfection
control b-galactosidase. There was no change in Renilla luciferase activity in insulin treated cells. All experiments were performed on at least four
independent occasions.
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start site) contained the minimal active IRES element
(Figure 4A). The IGF-1R mRNA has an even longer
50-UTR (1038 nt in human, 943 nt in rat) and has the
potential to form stable secondary structure which is
inhibitory to scanning by the 43S ribosomal complex
(18,40,41). The IGF-1R IRES has been localized to a
region of 85 nt immediately upstream of the translation
start site and downstream of the elements that are
proposed to be inhibitory to cap-dependent ribosomal
scanning (39). The 30-end of the 50-UTR is highly
pyrimidine-rich and predicted to form a stem loop struc-
ture (18).
Like many cellular IRESs the IR-IRES requires PTB
for activity in vivo and in vitro (Figure 3). Within cellular
IRESs PTB interacts with polypyrimidine rich sequences
that contain the motif CCU (4). The hIR 50-UTR contains
several such motifs, of which those at 6, 30, 93, 172, 387
and 456 relative to the transcription start site (535,
511, 448, 369, 154 and 85, respectively relative
to the translation start site) are conserved in the rat
(Figure 1). Moreover, two of these CCU motifs lie
within the minimal IRES-containing region (90–270)
defined by deletion mapping, which was also shown by
EMSA to bind PTB (Figure 4). A model of the structure
of the IR 50-UTR, derived by constraining the Mfold algo-
rithm with experimental data identifying double- and
single-stranded regions, predicts that the CCU motifs at
93 and 172 are both situated in bulges within stem struc-
tures (Figure 5) and that the structural context of the
motif at 172 would be preserved in the minimal active
IRES fragment. Thus, it is highly likely that binding of
PTB at one or both of the CCU motifs located at 93–95
and 172–174 (448–446 and 369–367 nt upstream of trans-
lation start site) is critical for IRES function.
The IGF-1R IRES also binds PTB (18) and several
other proteins, including the ELAV RNA stability factor
HuR, which is inhibitory to both cap-dependent scanning
and especially IRES-mediated translation, and hnRNP C
which competes with HuR for binding and enhances
IRES-mediated translation (39,41,42). It remains to be
seen whether these or other proteins also bind to the IR
IRES, although the differences in location and sequence
of the IR and IGF-1R IRESs are strongly suggestive of
different mechanisms of regulation.
The IR-IRES is similar to IRESs in the Apaf-1 and
N-myc 50-UTRs in that it is activated in vitro by nPTB
(Figure 4). Moreover, it is highly active in cell lines of
neuronal origin (Figure 6) which we have shown pre-
viously to express high levels of nPTB (29). Both IR and
IGF-1R are expressed in the nervous system and have
been proposed to function both during neuronal develop-
ment and in the adult brain (43–45). Indeed, the IR is
widely expressed throughout the adult brain (43), with
highest levels in the hypothalamus, olfactory bulb and
cerebellum, and a specific receptor-mediated transport
system exists for insulin at the blood brain barrier (46).
Numerous functions have been proposed for neuronal
insulin receptors, including roles in neurogenesis (47),
learning and memory (48), maintenance of energy balance
and reproductive function (49,50), and both protection
from and promotion of age-related neurodegenerative
diseases (49,51,52). It would not be surprising therefore
if sophisticated mechanisms exist to regulate the expres-
sion of brain IR in response to diverse stimuli.
It is known that in both fully differentiated tissues, such
as the brain, and in cells grown to high confluency there is
a reduction in cap-dependent ribosomal scanning of
mRNAs due to changes in the levels and/or phosphoryla-
tion states of the eIFs (53). IRESs can potentially be used
to maintain expression of key proteins in terminally differ-
entiated tissues. For instance, it has been shown that the
FGF-2-IRES (but not the c-myc-IRES) functions in adult
mouse brain (54). It is possible therefore that the IR-IRES
is active in certain (but not all) cells arrested in G0 and in
some terminally differentiated tissues, such as adult brain,
to maintain expression of the IR and/or to allow regula-
tion of that expression in response to external stimuli.
We found that the activity of the IR-IRES was depen-
dent not only on cell type but also on cell density. In
common with the PKCd IRES (55) the IR-IRES was
most active at high cell density (Figure 5B), when levels
of total protein synthesis will be reduced. However, cellu-
lar IRESs found in the 50-UTRs of Apaf-1, c-myc or Bag-1
are not sensitive to changes in cell density (unpublished
data). Insulin itself stimulated IRES activity in
sub-confluent but not in confluent cells (Figure 7). In con-
trast, in Drosophila it was proposed that cap-dependent
translation is used for dINR synthesis when nutrients
and insulin-like peptides are available, and that the
dINR IRES is used to drive increased receptor synthesis
under conditions of low availability of nutrients and insu-
lin-like peptides, when transcription of the dINR gene is
enhanced while cap-dependent translation is inhibited by
dephosphorylation of d4E-BP (22). Interestingly, nutrient
and growth factor deprivation of cultured mouse muscle
cells was similarly accompanied by a 6- to 8-fold increase
in IR protein and 2-fold up-regulation of IR mRNA, sug-
gestive of an analogous FOXO-mediated coupled tran-
scription/translation response (26).
There is little published information describing regula-
tion of expression of mammalian IR at the level of mRNA
translation. The human IR mRNA is one of only a very
small number of transcripts that remain associated with
polysomes when cap-dependent translation is inhibited
by poliovirus infection (6), consistent with IRES-
dependent translation initiation under these conditions.
However, studies of factors determining IR expression
in different mammalian tissues and under different
patho-physiological conditions have focused on mRNA
transcription and protein degradation as regulatory
mechanisms. It is possible that the IR-IRES simply func-
tions to maintain expression of IR under conditions where
cap-dependent initiation is compromised, including per-
haps in some differentiated cells. However, in the case of
the IGF-1R there is evidence that regulation of expression
does occur at a translational level. The IGF-1R was
among a number of transcripts shown by cDNA array
screening of polysome-associated mRNAs to be transla-
tionally regulated during antigenic stimulation of human
T-lymphocytes, although underlying mechanisms were not
investigated (56). Recently, it was shown that binding of
inhibitory HuR and stimulatory hnRNP C to the IGF-1R
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IRES was influenced by changes in cellular environment
or proliferative status, and it was suggested that dysregu-
lation of the IGF-1R-IRES through changes in expression
of RNA-binding translational-regulatory proteins could
contribute to over-expression of IGF-1R in some tumours
(39). It will be interesting now to investigate whether the
IR-IRES is similarly capable of dynamic regulation, and
whether this influences the expression of IR protein under
different patho-physiological conditions, especially in
neuronal tissues.
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